UnitedHealthcare to Cut Out-of-Pocket Costs on Insulin, Other Drugs
15 Julho 2022 - 12:05PM
Dow Jones News
By Dean Seal
UnitedHealthcare, the health-insurance arm of UnitedHealth Group
Inc., said Friday that it would eliminate out-of-pocket costs for
certain prescription drugs, including insulin and treatments used
in emergency situations.
The unit of the healthcare and health-insurance company said the
new standard offering could potentially be made available to its
fully insured group plans by the start of next year.
Drugs covered under the offering would include treatments for
emergencies such as severe allergic reactions, hypoglycemia, opioid
overdoses and acute asthma attacks.
The company said cutting expenses for those medications can help
reduce overall medical costs on consumers and encourage better
adherence to medication schedules, which in turn would reduce the
risk of complications or pricy hospital stays.
"We are doing what we can to shield people from the prices set
by pharmaceutical companies, and hope all stakeholders also will
act to make prescription drugs more affordable," said Brian
Thompson, chief executive of UnitedHealthcare.
For the second quarter, UnitedHealth's insurance business added
280,000 members and reported $62.1 billion in revenue, up from
$55.5 billion in the same period a year ago.
Shares rose 4.3%, to $524, in early trading Friday.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
July 15, 2022 10:50 ET (14:50 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
UnitedHealth (NYSE:UNH)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
UnitedHealth (NYSE:UNH)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024
